CGEM vs REGN: Which Stock is Better?
Side-by-side comparison of Cullinan Oncology LLC and Regeneron Pharmaceuticals Inc in 2026
CGEM
Cullinan Oncology LLC
—
REGN
Regeneron Pharmaceuticals Inc
$654.27
Key Metrics Comparison
| Metric | CGEM | REGN | Winner |
|---|---|---|---|
| Market Cap | $830.30M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CGEM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGEM or REGN a better investment?
Comparing CGEM and REGN: Cullinan Oncology LLC has a market cap of $830.30M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGEM and REGN?
CGEM (Cullinan Oncology LLC) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGEM or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGEM or REGN?
Both CGEM and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CGEM or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CGEM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $830.30M for CGEM.
Should I buy CGEM or REGN in 2026?
Both CGEM and REGN have investment merit. CGEM trades at $N/A while REGN trades at $654.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGEM and REGN stock?
Key differences: Market Cap ($830.30M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CGEM or REGN in 2026?
The choice between CGEM and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CGEM and REGN?
CGEM (Cullinan Oncology LLC) has a market cap of $830.30M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.